DOI: 10.1128/AAC.00554-15
Article Information
PubMed
Published By
History
- Received March 11, 2015
- Returned for modification June 25, 2015
- Accepted August 25, 2015
- Published online November 16, 2015.
Copyright & Usage
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (September 14, 2015).
- You are viewing the most recent version of this article.
Author Information
- Ilias Karaiskosa,
- Lena E. Fribergb,
- Konstantinos Pontikisc,
- Konstantinos Ioannidisd,
- Vasiliki Tsagkaric,
- Lamprini Galania,
- Eirini Kostakouc,
- Fotini Baziakaa,
- Charalambos Paskalise,
- Antonia Koutsoukouc and
- Helen Giamarelloua
- a6th Department of Internal Medicine, Hygeia General Hospital, Athens, Greece
- bDepartment of Pharmaceutical Biosciences, Uppsala University, Sweden
- c1st Department of Respiratory Diseases–Intensive Care Unit, Sotiria Hospital, Greece
- dClinical Pharmacist, Hygeia General Hospital, Athens, Greece
- eIntensive Care Unit, Hygeia General Hospital, Athens, Greece
- Address correspondence to Ilias Karaiskos, iliaskaraiskos{at}gmail.com.
I.K. and L.E.F. contributed equally to this work.
Citation Karaiskos I, Friberg LE, Pontikis K, Ioannidis K, Tsagkari V, Galani L, Kostakou E, Baziaka F, Paskalis C, Koutsoukou A, Giamarellou H. 2015. Colistin population pharmacokinetics after application of a loading dose of 9 MU colistin methanesulfonate in critically ill patients. Antimicrob Agents Chemother 59:7240–7248. doi:10.1128/AAC.00554-15.
